3rd Quarter - Report
DLA PIPER LLP (US) for AVALYN PHARMA INC.
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues related to lung disease and rare disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| MAREN MCBRIDE | — |
Health Issues HCR
Issues related to lung disease and rare disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| MAREN MCBRIDE | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.